Global News

Pfizer releases top-line data from phase III study of tofacitinib in RA

Friday, August 3, 2012 11:24 AM

Pfizer reported today top-line results from ORAL Start (A3921069), a phase III study of the investigational agent tofacitinib, a novel, oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA).

More... »

Teva appoints two to executive team

Friday, August 3, 2012 11:07 AM

Teva Pharmaceutical, a global pharmaceutical company based in Israel, has appointed Dr. Carlo De Notaristefani as president and CEO of global operations and Aharon (Arik) Yaari as executive vice president of newly created community and institutional affairs.

More... »

OPKO Health acquires Farmadiet Group Holding

Friday, August 3, 2012 10:38 AM

OPKO Health, a global biopharmaceutical and diagnostics company, has decided to acquire Farmadiet Group Holding, a Spanish company that develops, manufactures and markets pharmaceutical, nutraceutical and veterinary products.

More... »

Gilead collaborates with Indian partners to reduce costs, improve availability of antiretroviral therapy

Thursday, August 2, 2012 02:44 PM

Pharmaceutical companies Gilead Sciences, Mylan Laboratories, Ranbaxy Laboratories and Strides Arcolab have entered into agreements to collaborate on promoting access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine (FTC) in developing countries, including single tablet regimens containing emtricitabine and fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines.

More... »

AmerisourceBergen signs 3 year supply agreement with Express Scripts

Thursday, August 2, 2012 09:56 AM

AmerisourceBergen, a global pharmaceutical services company based in Valley Forge, Penn., has signed a three year agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis, effective October 1, 2012.

More... »

Clinical Resource Network changes name to Symphony Clinical Research

Thursday, August 2, 2012 09:48 AM

Clinical Resource Network (CRN), a global provider of in-home and alternate-site clinical services to patients in clinical trials, has changed its name to Symphony Clinical Research.

More... »

Prosetta, BMS form multi-year antiviral drug development collaboration

Wednesday, August 1, 2012 01:56 PM

Prosetta Antiviral, a San Francisco-based biotechnology company, has formed a strategic alliance with global biopharmaceutical company Bristol-Myers Squibb (BMS) to further discover and develop select drug candidates representing new, novel classes of antiviral drugs.

More... »

Rejected Alzheimer's drug shows new potential

Wednesday, August 1, 2012 11:42 AM

An international team of scientists led by researchers at Mount Sinai School of Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012, in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients with early stages of the disease.

More... »

Anchor, Kyowa Hakko Kirin collaborate on pepducin tech for GPCR targets

Wednesday, August 1, 2012 11:15 AM

Anchor Therapeutics, a developer of pepducin technology, has entered into a collaborative agreement with Kyowa Hakko Kirin (KHK), a Japanese biopharmaceutical company, to advance KHK’s internal G protein-coupled receptor (GPCR) drug discovery portfolio.

More... »

Illumina determines BaseSpace pricing for data storage and processing

Monday, July 30, 2012 03:22 PM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, has announced the pricing for BaseSpace, the company's genomics cloud computing and storage platform.

More... »